おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Aldatu Biosciences
company
About
Aldatu Biosciences is changing infectious disease treatment paradigms through innovative diagnostic solutions.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.50M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 7, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Aldatu Biosciences is a Boston, MA-based, early-stage biotechnology company developing innovative diagnostic tools based on its proprietary genotyping platform, PANDAA. Aldatu is committed to commercializing products that address diagnostic challenges in global health, primarily in HIV and other infectious diseases, and which improve both the quality of patient care and healthcare cost-efficiency.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$4.60M
Aldatu Biosciences has raised a total of
$4.60M
in funding over 2 rounds. Their latest funding was raised on
Feb 8, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 8, 2017 | Grant | $3M | 1 |
National Institutes of Health
|
— | Detail |
| Feb 23, 2016 | Convertable Note | $100K | 1 | — | — | Detail |
| Jun 1, 2015 | Grant | $1.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Aldatu Biosciences is funded by 2 investors.
National Institutes of Health
and CH Innovations
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
|
— | Convertable Note |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
